TSPAN8 and cancer: Apart from their diagnostic applications, TSPAN8 has also been recognized as a promising target for several therapeutic strategies, as multiple monoclonal anti-TSPAN8 antibodies have shown significant efficacy in pre-clinical cancer models, and CAR-T cells have efficiently targeted TSPAN8-expressing cancer cells (Figure 4).